Methods of treating blepharospasm using cyclosporine components

Details Methods of treating blepharospasm using cyclosporine components Methods of treating blepharospasm using cyclosporine components

2007-02-12

2010-02-02

Kosar, Andrew D (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

Reexamination Certificate

active

07655625

ABSTRACT:
Methods of treating humans or animals afflicted with primary blepharospasm, for example, benign essential blepharospasm, or secondary blepharospasm not caused by an ocular surface disease or condition, are component to a human or animal so afflicted.

REFERENCES:
patent: 5411952 (1995-05-01), Kaswan
patent: 7135455 (2006-11-01), Stern et al.
patent: 7151085 (2006-12-01), Stern et al.
patent: 7368426 (2008-05-01), Stern et al.
patent: 2004/0106546 (2004-06-01), Napoli
patent: 1591129 (1994-12-01), None
patent: WO00/61168 (2000-10-01), None
KirschenMcLoon,et al., “Cyclosporing Protests the Eyelid Skin From Injury After Injection of Doxorubicin,” Investigative Ophtalmology & Visual Sicence, Jun. 1995, vol. 36, No. 7, pp. 1433-1440 XP002439304.

Affiliated with

Also associated with

Rating

Methods of treating blepharospasm using cyclosporine components does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treating blepharospasm using cyclosporine components, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating blepharospasm using cyclosporine components will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4154025